Profil zamawiającego
HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS
ES- Zamówienia
- 195
- Łączna wartość zamówień
- 304 751 126 €
- Kraje
- Hiszpania
- Ostatnie zamówienie
- 2 lip 2026
- Wygasają w ciągu 12 miesięcy
- 0
Historia zamówień
| Data | Wykonawca | Tytuł | Kategoria | Wartość | Kraj | Wygasa | Źródło |
|---|---|---|---|---|---|---|---|
| 02.07.2026 | LILLY S.A. | Spain – Immunosuppressive agents – PNSP HUPA 33/26 | Produkty farmaceutyczne | 190,7 tys. € | ES | — | Zobacz w TED ↗ |
| 02.07.2026 | AMGEN, S.A. | Spain – Antineoplastic agents – PNSP HUPA 18/26 | Produkty farmaceutyczne | 129,2 tys. € | ES | — | Zobacz w TED ↗ |
| 11.06.2026 | NOVARTIS FARMACÉUTICA S.A | Spain – Various medicinal products – PNSP HUPA 45/26 | — | 333,6 tys. € | ES | — | Zobacz w TED ↗ |
| 11.06.2026 | LOGISTA PHARMA, S.A.U. | Spain – Pharmaceutical products – Yorvipath 168 mcg/0,56 ml, Yorvipath 294 mcg/0,98 ml y Yorvipath 420 mcg /1,4 ml, plumas precargadas | — | 236,3 tys. € | ES | — | Zobacz w TED ↗ |
| 11.06.2026 | NOVARTIS FARMACÉUTICA S.A | Spain – Antineoplastic agents – Scemblix 40 mg comprimidos recubiertos con película | — | 235,6 tys. € | ES | — | Zobacz w TED ↗ |
| 26.05.2026 | GRIFOLS MOVACO, S.A. | Spain – Pharmaceutical products – PNSP HUPA 202/25 | — | 504,5 tys. € | ES | — | Zobacz w TED ↗ |
| 15.05.2026 | BEONE MEDICINES S.L.U. | Spain – Antineoplastic agents – PNSP HUPA 14/26 | — | 688,9 tys. € | ES | — | Zobacz w TED ↗ |
| 16.04.2026 | Neuraxpharm Spain, S.L.U. | Spain – Immunosuppressive agents – PNSP HUPA 194/25 | — | 103,8 tys. € | ES | — | Zobacz w TED ↗ |
| 20.03.2026 | Takeda Farmacéutica España, S.A. | Spain – Immune sera and immunoglobulins – PNSP 201/25 | — | 224,8 tys. € | ES | — | Zobacz w TED ↗ |
| 11.03.2026 | REGENERON SPAIN SLU | Spain – Antineoplastic and immunomodulating agents – PNSP HUPA 163/25 | — | 499,8 tys. € | ES | — | Zobacz w TED ↗ |
| 02.03.2026 | GE HEALTHCARE BIO-SCIENCIES, S.A.U. | Spain – Various medicinal products – Radiofármacos | — | 391,2 tys. € | ES | — | Zobacz w TED ↗ |
| 27.02.2026 | GILEAD SCIENCES S.L | Spain – Pharmaceutical products – PNSP HUPA 135/25 | — | 160,4 tys. € | ES | — | Zobacz w TED ↗ |
| 23.02.2026 | Astrazeneca Farmacéutica Spain, S.L. | Spain – Pharmaceutical products – PNSP HUPA 142/25 | — | 407,1 tys. € | ES | — | Zobacz w TED ↗ |
| 23.02.2026 | ARGENX SPAIN S.L. | Spain – Immunosuppressive agents – PNSP HUPA 185/25 | — | 273,0 tys. € | ES | — | Zobacz w TED ↗ |
| 23.02.2026 | GLAXOSMITHKLINE, S.A. | Spain – Antineoplastic agents – PNSP HUPA 141/25 | — | 429,4 tys. € | ES | — | Zobacz w TED ↗ |
| 20.02.2026 | ABBVIE SPAIN, S.L.U. | Spain – Antineoplastic agents – PNSP HUPA 79/25 | — | 149,3 tys. € | ES | — | Zobacz w TED ↗ |
| 20.02.2026 | Curium Pharma Spain, S.A. | Spain – Pharmaceutical products – PNSP HUPA 71/25 | — | 101,8 tys. € | ES | — | Zobacz w TED ↗ |
| 20.02.2026 | Bristol Myers Squibb. S.A.U. | Spain – Pharmaceutical products – PNSP HUPA 61/25 | — | 136,3 tys. € | ES | — | Zobacz w TED ↗ |
| 20.02.2026 | GILEAD SCIENCES S.L | Spain – Pharmaceutical products – PNSP HUPA 131/25 | — | 160,4 tys. € | ES | — | Zobacz w TED ↗ |
| 20.02.2026 | ROCHE FARMA SAU | Spain – Antineoplastic agents – PNSP HUPA 83/25 | — | 179,9 tys. € | ES | — | Zobacz w TED ↗ |
| 20.02.2026 | JANSSEN-CILAG, S.A. | Spain – Pharmaceutical products – PNSP HUPA 62/25 | — | 782,0 tys. € | ES | — | Zobacz w TED ↗ |
| 29.12.2025 | BLÁZQUEZ INGENIERÍA S.L. | Spain – Medical equipments – PNSP HUPA 167/25 | — | 80,9 tys. € | ES | — | Zobacz w TED ↗ |
| 07.11.2025 | JOHNSON & JOHNSON, S.A. | Spain – Breast prostheses – IMPLANTES PRÓTESIS MAMARIAS Y EXPANSORES | — | 378,0 tys. € | ES | — | Zobacz w TED ↗ |
| 06.11.2025 | ROCHE FARMA SAU | Spain – Antineoplastic agents – PNSP HUPA 60/25 | — | 94,4 mln € | ES | — | Zobacz w TED ↗ |
| 06.11.2025 | OLYMPUS IBERIA S A | Spain – Medical consumables – MATERIAL DE ENDOSCOPIAS CPRE Y VARIOS | — | 400,9 tys. € | ES | — | Zobacz w TED ↗ |
| 23.10.2025 | SAKURA FINETEK SPAIN, S.L.U. | Spain – Medical equipments – PNSP HUPA 129/25 | — | 277,0 tys. € | ES | — | Zobacz w TED ↗ |
| 23.10.2025 | BIONET MEDICAL, S.L. | Spain – Pharmaceutical products – PNSP HUPA 110/25 | — | 244,0 tys. € | ES | — | Zobacz w TED ↗ |
| 22.10.2025 | ADVANCED ACCELERATOR APPLICATIONS IBERICA, S.L.U. | Spain – Pharmaceutical products – PNSP HUPA 16/25 | — | 186,6 tys. € | ES | — | Zobacz w TED ↗ |
| 20.10.2025 | ADVANCED ACCELERATOR APPLICATIONS IBERICA, S.L.U. | Spain – Pharmaceutical products – PNSP HUPA 16/24 | — | 186,6 tys. € | ES | — | Zobacz w TED ↗ |
| 20.10.2025 | ROCHE FARMA SAU | Spain – Pharmaceutical products – PNSP HUPA 112/25 | — | 131,7 tys. € | ES | — | Zobacz w TED ↗ |
| 20.10.2025 | Casa Álvarez Material Científico S.A | Spain – Diagnostic supplies – PNSP HUPA 130/25 | — | 1,3 mln € | ES | — | Zobacz w TED ↗ |
| 09.10.2025 | SPINEART ESPAÑA, S.L.U. | Spain – Surgical implants – IMPLANTES COLUMNA PARA EL HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS | — | 688,3 tys. € | ES | — | Zobacz w TED ↗ |
| 06.10.2025 | Sysmex España, S.L.U. | Spain – Laboratory reagents – PNSP HUPA 17/25 | — | 156,4 tys. € | ES | — | Zobacz w TED ↗ |
| 01.10.2025 | CSL BEHRING, S.A. | Spain – Immune sera and immunoglobulins – PA HUPA 67/25 | — | 100,7 mln € | ES | — | Zobacz w TED ↗ |
| 09.09.2025 | FRESENIUS MEDICAL CARE ESPAÑA, S.A.U. | Spain – Renal dialysis consumables – MATERIAL FUNGIBLE PARA HEMODIÁLISIS | — | 458,0 tys. € | ES | — | Zobacz w TED ↗ |
| 24.06.2025 | LILLY S.A. | Spain – Antineoplastic agents – PNSP HUPA 50/25 | — | 133,8 tys. € | ES | — | Zobacz w TED ↗ |
| 20.06.2025 | B, BRAUN MEDICAL, S,A, | Spain – Medical consumables – Bombas Infusores Electrónicos Volumétricos | — | 2,5 mln € | ES | — | Zobacz w TED ↗ |
| 11.06.2025 | PFIZER, S.L. | Spain – Antineoplastic agents – PNSP HUPA 102/24 | — | 208,8 tys. € | ES | — | Zobacz w TED ↗ |
| 13.05.2025 | ABBVIE SPAIN, S.L.U. | Spain – Pharmaceutical products – PNSP HUPA 101/24 | — | 145,7 tys. € | ES | — | Zobacz w TED ↗ |
| 04.04.2025 | FUJIFILM SPAIN, S.L | Spain – Reagents and contrast media – REACTIVOS Y FUNGIBLES PARA TÉCNICAS DE REPRODUCCÍON ASISTIDA PARA EL HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS | — | 594,2 tys. € | ES | — | Zobacz w TED ↗ |
| 07.11.2024 | PROSAC PRODUCTOS S.L. | Spain – Pharmaceutical products – PA HUPA 70/24 | — | 137,5 tys. € | ES | — | Zobacz w TED ↗ |
| 04.10.2024 | EURO AUTOMATION, S.L. | Spain – Artificial parts of the body – Consumibles para Contrastes Radiológicos mediante Inyectores | — | 372,8 tys. € | ES | — | Zobacz w TED ↗ |
| 02.10.2024 | NOVARTIS FARMACÉUTICA S.A | Spain – Antineoplastic agents – PNSP HUPA 79/24 | — | 153,6 tys. € | ES | — | Zobacz w TED ↗ |
| 19.09.2024 | LABORATORIOS SERVIER SL | Spain – Antineoplastic agents – PNSP HUPA 54/24 | — | 164,3 tys. € | ES | — | Zobacz w TED ↗ |
| 19.09.2024 | Astrazeneca Farmacéutica Spain, S.L. | Spain – Pharmaceutical products – PNSP HUPA 69/24 | — | 156,6 tys. € | ES | — | Zobacz w TED ↗ |
| 18.09.2024 | ASTELLAS PHARMA, S.A. | Spain – Antineoplastic agents – PNSP HUPA 39/24 | — | 191,3 tys. € | ES | — | Zobacz w TED ↗ |
| 03.07.2024 | UCB Pharma, S.A. | Spain – Antineoplastic and immunomodulating agents – PNSP HUPA 17/24 | — | 122,7 tys. € | ES | — | Zobacz w TED ↗ |
| 02.07.2024 | LABORATORIOS LEO PHARMA, S.A. | Spain – Immunosuppressive agents – PNSP HUPA 15/24 | — | 97,4 tys. € | ES | — | Zobacz w TED ↗ |
| 19.06.2024 | GINEFIV, S.L | Spain – Medical consumables – Ovocitos de donante | — | 875,0 tys. € | ES | — | Zobacz w TED ↗ |
| 17.06.2024 | DIAVERUM SERVICIOS RENALES, S.L. | Spain – Nephrology or nervous system specialist services – Tratamiento de Hemodiálisis Extrahospitalaria para Pacientes del Hospital Universitario Príncipe de Asturias | — | 314,2 tys. € | ES | — | Zobacz w TED ↗ |